| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATPase family AAA domain containing 2B | 0.760 | 0.192 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
autophagy related 7 | 0.505 | 0.769 | 7.4E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
ATP synthase membrane subunit DAPIT | 0.821 | 0.231 | 4.8E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
ATP synthase membrane subunit g | 1.000 | 0.038 | 4.4E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
ATPase H+ transporting V1 subunit B2 | 0.606 | 0.577 | 0.99 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
activator of transcription and developmental regulator AUTS2 | 0.569 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
beta 3-glucosyltransferase | 0.554 | 0.731 | 7.1E-17 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
BAR/IMD domain containing adaptor protein 2 | 0.769 | 0.192 | 0.46 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||
|
bromodomain adjacent to zinc finger domain 1A | 0.792 | 0.269 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BBX high mobility group box domain containing | 0.839 | 0.231 | 0.52 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||
|
BCAR3 adaptor protein, NSP family member | 0.695 | 0.654 | 0.58 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
BEN domain containing 4 | 0.839 | 0.154 | 0.98 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
basic helix-loop-helix family member e41 | 0.623 | 0.577 | 0.99 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BRD4 interacting chromatin remodeling complex associated protein | 0.695 | 0.269 | 0.98 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BORCS7-ASMT readthrough (NMD candidate) | 0.805 | 0.154 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||
|
butyrophilin subfamily 2 member A1 | 0.722 | 0.423 | 3.4E-21 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
butyrophilin subfamily 3 member A1 | 0.780 | 0.269 | 5.9E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
butyrophilin subfamily 3 member A2 | 0.716 | 0.462 | 1.1E-10 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
chromosome 11 open reading frame 49 | 0.931 | 0.077 | 2.2E-11 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||
|
chromosome 4 open reading frame 33 | 0.931 | 0.038 | 3.5E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
chromosome 5 putative open reading frame 17 | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
chromosome 6 open reading frame 99 | 0.931 | 0.115 | 0.13 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.700 | None | 1.000 | 3 | 3 | 2010 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 E | 0.650 | 0.577 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1 | 0.641 | 0.500 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 |